Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The Unpublished Phase I Trial: A Critical Look A pivotal point of discussion is the Phase I clinical trial for BPC-157 in patients with IBD, registered on ClinicalTrials.gov
It can mimic Alzheimers disease, multiple sclerosis, early Parkinsons disease, diabetic neuropathy, or chronic fatigue syndrome
GLP-3 (Reta) is an investigational compound developed by Eli Lilly and remains in clinical development
BPC-157 has also been applied topically in several animal studies into its wound-healing capabilities
US$ 28.75
US$ 29.76
US$ 22.96
US$ 23.63
